Guardant Health, Inc. Common Stock (GH) News
Latest headlines that mention GH, newest first · each headline opens the original publisher
- Last price
- $160.28
- Day change
- -3.83%
- Next earnings
- 2026-11-05 AMC
GH headlines
latest coverageEarning a spot on the IBD Leaderboard and IBD 50, Guardant Health stress tests a breakout. The post AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why. appeared first on Investor's Business Daily .
Guardant Health provides services across the cancer continuum. Shares are near a buy point of 176.58 after a breakout. The post Guardant Health Nears Buy Point As Sales Outlook Brightens appeared first on Investor's Business Daily .
Guardant Health stock tumbled Monday after losing a patent battle against privately held TwinStrand Biosciences. The post Guardant Health Dives After Losing A Patent Dispute; Judge Orders Royalties appeared first on Investor's Business Daily .
Shield screening volumes more than doubled, with UnitedHealth coverage now active.
The colon cancer screening test provider posted a revenue beat-and-raise. The post Guardant Health, Thursday's Stock Of The Day, Spikes After Hiking 2026 Outlook appeared first on Investor's Business Daily .
GH news alerts
Get an alert by email or push when a new headline mentions GH.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.